ATE338533T1 - Hautcremezusammensetzung - Google Patents
HautcremezusammensetzungInfo
- Publication number
- ATE338533T1 ATE338533T1 AT01993455T AT01993455T ATE338533T1 AT E338533 T1 ATE338533 T1 AT E338533T1 AT 01993455 T AT01993455 T AT 01993455T AT 01993455 T AT01993455 T AT 01993455T AT E338533 T1 ATE338533 T1 AT E338533T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- conjugated
- skin cream
- cream composition
- well
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20005718A NO310176B1 (no) | 2000-11-13 | 2000-11-13 | Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE338533T1 true ATE338533T1 (de) | 2006-09-15 |
Family
ID=19911788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01993455T ATE338533T1 (de) | 2000-11-13 | 2001-11-01 | Hautcremezusammensetzung |
Country Status (10)
Country | Link |
---|---|
US (1) | US7557094B2 (de) |
EP (1) | EP1341517B1 (de) |
AT (1) | ATE338533T1 (de) |
AU (1) | AU2002216473A1 (de) |
DE (1) | DE60122927T2 (de) |
DK (1) | DK1341517T3 (de) |
ES (1) | ES2272566T3 (de) |
NO (1) | NO310176B1 (de) |
PT (1) | PT1341517E (de) |
WO (1) | WO2002038123A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO310176B1 (no) * | 2000-11-13 | 2001-06-05 | Wadlund As | Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne |
ITMI20010347A1 (it) * | 2001-02-21 | 2002-08-21 | Grisotech S A | Complessi di immunoglobuline e polisaccaridi per assorbimento orale etrans-mucosale |
DE10253042A1 (de) * | 2002-11-14 | 2004-06-03 | Wacker-Chemie Gmbh | Kosmetische Zubereitung enthaltend einen Komplex aus Cyclodextrin und Vitamin F |
GB0311081D0 (en) * | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
CH698539A8 (de) | 2003-08-18 | 2009-10-15 | Btg Int Ltd | Verbindungen mit ungesättigten Fettsäureresten zur Herstellung von Medikamenten zur Behandlung von multipler Sklerose. |
GB0425932D0 (en) * | 2004-11-25 | 2004-12-29 | Btg Int Ltd | Structured phospholipids |
ES2310948B2 (es) * | 2005-02-25 | 2009-09-16 | Universidade De Santiago De Compostela | Procedimiento de obtencion de hidrogeles de ciclodextrinas con glicidileteres, las composiciones obtenidas y sus aplicaciones. |
GB0504362D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
GB0504333D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Treatment of cytokine dysregulation |
US20060240116A1 (en) * | 2005-04-22 | 2006-10-26 | David Jolley | Bioactive factors in wound healing topical compositions and methods |
US20070116778A1 (en) * | 2005-11-22 | 2007-05-24 | Fierro Arthur A | Antibacterial, antiviral, and antifungal nutritional supplement: a combination of natural or neutraceutical compounds shown to have antibacterial, antiviral, and antifungal properties, to help boost the immune system in humans, and to protect against certain biowarfare diseases |
ITRM20060108A1 (it) * | 2006-03-03 | 2007-09-04 | Colella Gino | Composizioni a base di melatonina e sostanze immunostimolanti |
NO326950B1 (no) * | 2006-09-20 | 2009-03-16 | Pharma Medico Res Ltd | Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks |
EP1958639A1 (de) | 2007-02-14 | 2008-08-20 | Polichem S.A. | Verwendung von Chitosanen zur Behandlung von Entzündungserkrankungen der Nägel |
US9132296B2 (en) | 2007-05-17 | 2015-09-15 | Ag Essence | Antimicrobial solution and methods of making and using the same |
US9393261B2 (en) * | 2011-07-22 | 2016-07-19 | Body Glide LLC | Antimicrobial anti-chafing chelated silver oxide compound |
US20080312174A1 (en) * | 2007-06-05 | 2008-12-18 | Nitto Denko Corporation | Water soluble crosslinked polymers |
JP2010539245A (ja) * | 2007-09-14 | 2010-12-16 | 日東電工株式会社 | 薬物担体 |
KR101123366B1 (ko) | 2008-06-26 | 2012-03-23 | (주)바이오제닉스 | 우수한 안정성을 갖는 항산화제와 키토산과의 복합체 |
WO2010028652A1 (en) | 2008-09-12 | 2010-03-18 | Nanoko A/S | Colostrum composition |
KR101346661B1 (ko) * | 2010-11-15 | 2014-02-06 | 부경대학교 산학협력단 | 키토올리고당을 포함하는 피부 노화 방지용 화장료 조성물 |
US11547116B2 (en) * | 2012-12-12 | 2023-01-10 | William Wingfield | Metal oxide compounds and infusion into polymer compounds |
US20140234433A1 (en) * | 2013-02-15 | 2014-08-21 | Nicholas V. Perricone | Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin |
CN114652636B (zh) * | 2022-03-10 | 2023-11-17 | 广东丸美生物技术股份有限公司 | 一种抗皱修复组合物及其制备方法和包含该组合物的化妆品 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH675535A5 (de) * | 1988-11-28 | 1990-10-15 | Nestle Sa | |
FR2651131B1 (fr) | 1989-08-23 | 1994-05-20 | Roussel Uclaf | Nouvelles compositions cosmetiques contenant du chitosane et de la glucosamine. |
SE9300971D0 (sv) * | 1993-03-24 | 1993-03-24 | Jan Wadstein | Hudvaardskomposition |
EP0637450A3 (de) | 1993-08-04 | 1995-04-05 | Collagen Corp | Verfahren und Zusammensetzung zur Wiederbelebung von Nerbgewebe. |
DE19537297A1 (de) * | 1995-07-07 | 1997-01-09 | Paerson & Co Gmbh & Co | Kosmetische Präparate mit Wachstumsfaktoren hergestellt aus Milch und Kolostrum von Kühen und Stuten |
NO304009B1 (no) | 1997-02-04 | 1998-10-12 | Gunnar Volden | Hudpreparat |
US6019990A (en) * | 1997-11-21 | 2000-02-01 | Natural Nutrition Ltd. As | Conjugated linoleic acid delivery system in cosmetic preparations |
EP1041979A4 (de) * | 1997-12-23 | 2001-10-04 | Dcv Inc | Ester von konjugierter linolsäure oder konjugierter linolensäure und deren verwendung |
AU3061199A (en) | 1998-03-31 | 1999-10-18 | Jan Wadstein | Skin treatment compositions and the use thereof |
GB9828379D0 (en) | 1998-12-22 | 1999-02-17 | Unilever Plc | Skin care composition |
GB9828380D0 (en) | 1998-12-22 | 1999-02-17 | Unilever Plc | Skin lightening composition |
EP1180940A2 (de) * | 1999-03-31 | 2002-02-27 | KAPITZ, Carl-Heinz | Wirkstoff und wirkstoffkombination für mensch und tier |
GB9918025D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
NO310176B1 (no) * | 2000-11-13 | 2001-06-05 | Wadlund As | Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne |
-
2000
- 2000-11-13 NO NO20005718A patent/NO310176B1/no not_active IP Right Cessation
-
2001
- 2001-11-01 AU AU2002216473A patent/AU2002216473A1/en not_active Abandoned
- 2001-11-01 AT AT01993455T patent/ATE338533T1/de active
- 2001-11-01 DE DE60122927T patent/DE60122927T2/de not_active Expired - Lifetime
- 2001-11-01 ES ES01993455T patent/ES2272566T3/es not_active Expired - Lifetime
- 2001-11-01 WO PCT/NO2001/000437 patent/WO2002038123A1/en active IP Right Grant
- 2001-11-01 PT PT01993455T patent/PT1341517E/pt unknown
- 2001-11-01 EP EP01993455A patent/EP1341517B1/de not_active Expired - Lifetime
- 2001-11-01 DK DK01993455T patent/DK1341517T3/da active
- 2001-11-01 US US10/416,671 patent/US7557094B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK1341517T3 (da) | 2007-01-08 |
NO20005718A (no) | 2001-06-05 |
ES2272566T3 (es) | 2007-05-01 |
WO2002038123A1 (en) | 2002-05-16 |
PT1341517E (pt) | 2007-01-31 |
DE60122927D1 (de) | 2006-10-19 |
US20040043963A1 (en) | 2004-03-04 |
NO310176B1 (no) | 2001-06-05 |
NO20005718D0 (no) | 2000-11-13 |
EP1341517B1 (de) | 2006-09-06 |
US7557094B2 (en) | 2009-07-07 |
EP1341517A1 (de) | 2003-09-10 |
AU2002216473A1 (en) | 2002-05-21 |
DE60122927T2 (de) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60122927D1 (de) | Hautcremezusammensetzung | |
AU6720000A (en) | New process for the preparation of conjugated linoleic acid (cla) | |
ATE412417T1 (de) | Topische zusammensetzung zur behandlung von psoriasis und verwandten hautkrankheiten | |
WO2002019981A3 (en) | Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use | |
GB2394662A (en) | Topical composition for treating pain | |
IL154888A (en) | Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid | |
BR9913589A (pt) | Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição | |
CA2396186A1 (en) | Agents for the treatment of skin disorders | |
EA200700044A1 (ru) | Композиция для местного применения | |
WO2005025486A8 (en) | Skincare compositions comprising salicyclic acid | |
FI862609A (fi) | Akne motverkande produkt. | |
AU7233787A (en) | Novel topical metronidazole formulations and therapeutic uses thereof | |
MXPA06013179A (es) | Composicion anti-acne para el cuidado de la piel y articulo para el cuidado de la piel. | |
CA2157836A1 (en) | L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses | |
AU4711997A (en) | Use of zinc salts of conjugated linoleic acids to treat skin disorders | |
WO2005063195A3 (en) | Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers | |
PT1809383E (pt) | Composições cosméticas | |
HK1037126A1 (en) | Compositions for the treatment of acne. | |
WO2002030385A3 (de) | Entzündungshemmende wirkstoffe | |
CN102228414B (zh) | 一种含椰子油的化妆水及其生产方法 | |
GB2341317A (en) | A topical preparation for the promotion of hair growth or regrowth containing an absorption promoting agent and/or a blood thining agent | |
WO2017001707A1 (es) | Cosmética de aceite de bellota | |
FI20000956A (fi) | Kosmeettinen tai ihonhoidollinen voidekoostumus, sen valmistusmenetelmä ja käyttö | |
WO2003103625A3 (en) | DERMOCOSMETIC TREATMENT WITH METABOLIC PHOSPHOLIPIDS | |
WO2009142515A1 (en) | Cosmetic composition containing pancreatic enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1341517 Country of ref document: EP |